BIOMAT Database Logo BIOMAT Database Logo

Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients. 1979

C Ferrari, and P Travaglini, and R Caldara, and P Moriondo, and A Mattei, and P G Crosignani, and G Faglia

UI MeSH Term Description Entries
D008711 Metergoline A dopamine agonist and serotonin antagonist. It has been used similarly to BROMOCRIPTINE as a dopamine agonist and also for MIGRAINE DISORDERS therapy. Methergoline,Liserdol
D010902 Pituitary Gland A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM. Hypophysis,Hypothalamus, Infundibular,Infundibular Stalk,Infundibular Stem,Infundibulum (Hypophysis),Infundibulum, Hypophyseal,Pituitary Stalk,Hypophyseal Infundibulum,Hypophyseal Stalk,Hypophysis Cerebri,Infundibulum,Cerebri, Hypophysis,Cerebrus, Hypophysis,Gland, Pituitary,Glands, Pituitary,Hypophyseal Stalks,Hypophyses,Hypophysis Cerebrus,Infundibular Hypothalamus,Infundibular Stalks,Infundibulums,Pituitary Glands,Pituitary Stalks,Stalk, Hypophyseal,Stalk, Infundibular,Stalks, Hypophyseal,Stalks, Infundibular
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004873 Ergolines A series of structurally-related alkaloids that contain the ergoline backbone structure. Ergoline
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas

Related Publications

C Ferrari, and P Travaglini, and R Caldara, and P Moriondo, and A Mattei, and P G Crosignani, and G Faglia
Prolactin response to sulpiride in ovulatory women (a clue for the screening of hyperprolactinemic states).
January 1984, International journal of fertility,
C Ferrari, and P Travaglini, and R Caldara, and P Moriondo, and A Mattei, and P G Crosignani, and G Faglia
Failure of dopamine infusion to suppress the plasma prolactin response to sulpiride in normal and hyperprolactinemic subjects.
October 1977, The Journal of clinical endocrinology and metabolism,
C Ferrari, and P Travaglini, and R Caldara, and P Moriondo, and A Mattei, and P G Crosignani, and G Faglia
Metergoline abolishes the prolactin response to buspirone.
January 1990, Psychopharmacology,
C Ferrari, and P Travaglini, and R Caldara, and P Moriondo, and A Mattei, and P G Crosignani, and G Faglia
Inhibition of prolactin release by metergoline administration in man.
January 1977, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
C Ferrari, and P Travaglini, and R Caldara, and P Moriondo, and A Mattei, and P G Crosignani, and G Faglia
Metergoline treatment of hyperprolactinemic states.
September 1979, Fertility and sterility,
C Ferrari, and P Travaglini, and R Caldara, and P Moriondo, and A Mattei, and P G Crosignani, and G Faglia
Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
October 1977, Acta endocrinologica,
C Ferrari, and P Travaglini, and R Caldara, and P Moriondo, and A Mattei, and P G Crosignani, and G Faglia
Prolactin response to low dose sulpiride.
August 1987, British journal of clinical pharmacology,
C Ferrari, and P Travaglini, and R Caldara, and P Moriondo, and A Mattei, and P G Crosignani, and G Faglia
Treatment of hyperprolactinemic amenorrhea with Metergoline.
February 1986, Obstetrics and gynecology,
C Ferrari, and P Travaglini, and R Caldara, and P Moriondo, and A Mattei, and P G Crosignani, and G Faglia
Growth hormone and prolactin release in acromegalic patients following metergoline administration.
December 1976, The Journal of clinical endocrinology and metabolism,
C Ferrari, and P Travaglini, and R Caldara, and P Moriondo, and A Mattei, and P G Crosignani, and G Faglia
[Clinical results in the treatment with metergoline in 80 hyperprolactinemic patients].
September 1981, Minerva medica,
Copied contents to your clipboard!